文献速递颈动脉与弓上血管

原发性病变与动脉内膜切除术后再狭窄行颈动脉支架置入的再狭窄率及风险指数构建

Carotid Restenosis Rate After Stenting for Primary Lesions Versus Restenosis After Endarterectomy With Creation of Risk Index.
PubMed 文献 · J Endovasc Ther · 2022-04-25

本研究纳入2000年1月至2018年9月共782例患者,比较因原发性病变(440例)与动脉内膜切除术后再狭窄(342例)行颈动脉支架置入后的再狭窄率。两组再狭窄率无差异(8.7% vs 7.2%,p=0.406)。基于六个独立预测因子构建的颈动脉再狭窄风险指数(CRRI)评分>-4提示再狭窄风险增加。

要点

  • 颈动脉支架置入后原发性病变组与内膜切除术后再狭窄组再狭窄率无显著差异(8.7% vs 7.2%,p=0.406)。
  • 总体再狭窄率为7.9%,需再次干预的显著再狭窄(>70%)率为5.6%。
  • CRRI评分>-4为识别支架后高再狭窄风险患者的 criterion,需在未来随机试验中验证。

核心结论

  • 颈动脉支架置入后,原发性狭窄患者与动脉内膜切除术后再狭窄患者的再狭窄率无差异。
  • CRRI评分>-4可作为识别支架后高再狭窄风险患者的 criterion,该 criterion 需在未来随机试验中验证。

研究设计与样本

  • 回顾性研究,纳入2000年1月至2018年9月共782例患者,分为颈动脉支架(原发)组440例和颈动脉支架(再狭窄)组342例。
  • 支架置入指征为症状性狭窄/再狭窄>70%和无症状性狭窄/再狭窄>85%。
  • 支架置入后6个月、1年及之后每年行颈动脉彩色双功能超声检查,随访12至88个月,平均随访34.6±18.0个月。

主要发现

  • 颈动脉支架(原发)组与颈动脉支架(再狭窄)组再狭窄率无差异(8.7% vs 7.2%,χ2=0.691,p=0.406)。
  • 总体再狭窄率为7.9%,需再次干预的显著再狭窄(>70%)率为5.6%,两组间无差异(6.4% vs 4.7%,p=0.351)。
  • 再狭窄的六个独立预测因子为吸烟、合并既往心肌梗死和心绞痛、斑块形态、支架后痉挛、使用FilterWire或Spider Fx脑保护装置以及支架置入后时间。
  • 基于上述预测因子构建的颈动脉再狭窄风险指数(CRRI)范围为-7(最低风险)至+10(最高风险),评分>-4的患者再狭窄风险增加。
  • 两组神经和总体发病率及死亡率无差异。

关键数值与推荐

  • CRRI评分>-4为识别支架后高再狭窄风险患者的 criterion。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Carotid artery stenting (CAS) is an option for carotid restenosis (CR) treatment with favorable outcomes. However, CAS has also emerged as an alternative to carotid endarterectomy (CEA) for the management of patients with primary carotid stenosis. This study aimed to report CR rates after CAS was performed in patients with primary lesions versus restenosis after CEA, to identify predictors of CR, and to report both neurological and overall outcomes. MATERIALS AND METHODS: From January 2000 to September 2018, a total of 782 patients were divided into 2 groups: The CAS (prim) group consisted of 440 patients in whom CAS was performed for primary lesions, and the CAS (res) group consisted of 342 patients with CAS due to restenosis after CEA. Indications for CAS were symptomatic stenosis/restenosis >70% and asymptomatic stenosis/restenosis >85%. A color duplex scan (CDS) of carotid arteries was performed 6 months after CAS, after 1 year, and annually afterward. Follow-up ranged from 12 to 88 months, with a mean follow-up of 34.6±18.0 months. RESULTS: There were no differences in terms of CR rate between the patients in the CAS (prim) and CAS (res) groups (8.7% vs 7.2%, χ2=0.691, p=0.406). The overall CR rate was 7.9%, whereas significant CR (>70%) rate needing re-intervention was 5.6%, but there was no difference between patients in the CAS (prim) and CAS (res) groups (6.4% vs 4.7%, p=0.351). Six independent predictors for CR were smoking, associated previous myocardial infarction and angina pectoris, plaque morphology, spasm after CAS, the use of FilterWire or Spider Fx cerebral protection devices, and time after stenting. A carotid restenosis risk index (CRRI) was created based on these predictors and ranged from -7 (minimal risk) to +10 (maximum risk); patients with a score >-4 were at increased risk for CR. There were no differences in terms of neurological and overall morbidity and mortality between the 2 groups. CONCLUSIONS: There was no difference in CR rate after CAS between the patients with primary stenosis and restenosis after CEA. A CRRI score >-4 is a criterion for identifying high-risk patients for post-CAS CR that should be tested in future randomized trials.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Tanaskovic S, Sagic D, Radak D, et al. Carotid Restenosis Rate After Stenting for Primary Lesions Versus Restenosis After Endarterectomy With Creation of Risk Index. J Endovasc Ther. 2022. PMID: 35466778. doi:10.1177/15266028221091895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。